Drug Shortage Report for XATRAL
| Report ID | 196992 |
| Drug Identification Number | 02245565 |
| Brand name | XATRAL |
| Common or Proper name | Alfuzosin Hydrochloride |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALFUZOSIN HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-06-30 |
| Estimated end date | 2023-07-31 |
| Actual end date | 2023-07-20 |
| Shortage status | Resolved |
| Updated date | 2023-07-28 |
| Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-07-28 | French | Compare |
| v4 | 2023-07-28 | English | Compare |
| v3 | 2023-07-01 | English | Compare |
| v2 | 2023-06-30 | French | Compare |
| v1 | 2023-06-30 | English | Compare |
Showing 1 to 5 of 5